SKIN VERSUS PEMPHIGUS FOLIACEUS and the AUTOIMMUNE GANG Lara Luke, BS, RVT, Dermatology, Purdue Veterinary Teaching Hospital

Total Page:16

File Type:pdf, Size:1020Kb

SKIN VERSUS PEMPHIGUS FOLIACEUS and the AUTOIMMUNE GANG Lara Luke, BS, RVT, Dermatology, Purdue Veterinary Teaching Hospital VETERINARY NURSING EDUCATION SKIN VERSUS PEMPHIGUS FOLIACEUS AND THE AUTOIMMUNE GANG Lara Luke, BS, RVT, Dermatology, Purdue Veterinary Teaching Hospital This program was reviewed and approved by the AAVSB Learning Objective: After reading this article, the participant will be able to dis- RACE program for 1 hour of continuing education in jurisdictions which recognize AAVSB RACE approval. cuss and compare autoimmune diseases that have dermatological afects, includ- Please contact the AAVSB RACE program if you have any ing Pemphigus Foliaceus (PF), Pemphigus Erythematosus (PE), Discoid Lupus comments/concerns regarding this program’s validity or relevancy to the veterinary profession. Erythematosus (DLE), Systemic Lupus Erythematosus (SLE). In addition, the reader will become familiar with diagnostic and treatment techniques. FUNCTION OF THE SKIN Te skin is the largest organ of the body. Along with sensory function, it provides a barrier between the inside and outside world. Te epidermis is composed of the following fve layers: stratum basale, stratum spinosum, stratum granulosum, stratum lucidum, and stratum corneum. Te stratum lucidum is found only on the nasal planum and footpads. When the cells of the epidermis are disrupted by systemic disease, the barrier is also disrupted. Clinical signs of skin disease will bring the patient into the veterinarian’s ofce for diagnosis. 32 THE NAVTA JOURNAL | NAVTA.NET VETERINARY NURSING EDUCATION THE PEMPHIGUS COMPLEX article.3 Histologically it shares characteris- Pemphigus Foliaceus tics of both PF and DLE.1 This classifcation PF is an immune mediated pustular disor- is still considered controversial and PE may der included in a group of diseases known just be a localized variant of PF.1 as the pemphigus complex. It is one of fve recognized types in which the body Deeper Forms of the Pemphigus produces antibodies that target the proteins Complex binding the cells of the epidermis.1 It is The deeper forms of the pemphigus considered the number one autoimmune complex exhibit more serious signs. PV disease in dogs and cats, but has also been includes oral cavity and mucosal lesions. reported in humans, horses, and goats. Fever and anorexia often accompany der- matological signs. PVeg also includes oral Desmosomes are the proteins that bind lesions, but wart-like lesions and plaques keratinocytes (epidermal cells) to each can also be present. PPP is a deep form Figure 1 other. They are the target proteins in the of pemphigus associated with neopla- A 7-year-old M/N Cocker Spaniel with PF. pemphigus complex, which includes the sia, especially thymic lymphoma and superfcial diseases PF and pemphigus splenic sarcoma. There have only been erythematosus (PE), as well as the deeper two cases of canine PPP reported in the Ultraviolet light has been shown to trigger pemphigus diseases, pemphigus vulgaris literature and both are deceased. Immu- PF outbreaks. In addition, in the canine (PV), pemphigus vegetans (PVeg), and nologic investigation of deceased patients patient, PF has been associated with such paraneoplastic pemphigus (PPP).3 When revealed that, as in the human form, the disorders as chronic skin disease, hypo- the desmosomes are untethered from presence of autoantibodies against mem- thyroidism, and systemic lupus erythema- each other, the breakdown of these con- bers of the plakin family were present.3 tosus (SLE).2 nections is called acantholysis.3 Plakins are proteins involved in cellular development and tissue integrity.4 The DIAGNOSING PEMPHIGUS FOLIACEUS Clinical signs of PF are evident as pus- prognosis in humans is poor. Obtaining a cytology tules.2 Because the pustules are fragile If PF is on the doctor’s list of differentials, and rupture easily, they may not be visible Causes Of Pemphigus Foliaceus diagnosing the condition involves cytology on physical examination. The patient There are several factors that may play a and histopathology. It is ideal to obtain may present only with epidermal collar- part in the development of PF, although the an impression smear from the material of ets from the ruptured pustules, as well as specifc predisposing trigger may not be an intact pustule. Using a sterile needle, crusts, scales, and erosions.5 In the canine found in most cases.3 The frst cause often rupture the pustule and press a glass patient, hyperkeratosis of the footpads considered is genetics. In canines, different slide against the exudate. Pustules are may also be evident (Fig 1). papers have listed several different breeds fragile and rupture easily, so they may be reported with the disease. However, it can rare on physical exam. If only one pus- In felines, clinical signs of PF are similar be agreed upon that the two breeds over- tule is found, save that for histopathology. to dogs with lesions covering the pinnae, represented are Akitas and Chow Chows. Material can be obtained from beneath any periocular regions, and footpads. Like the Cats and horses have not proven any crust or collarette. Heat fx the slide and dog, it can become generalized. In cats, breed predilection.2,5 Similarly, evidence of stain with Diff-Quick stain. the claw folds can also be involved. Horses breed predilection for PF is missing in the tend to have a more generalized pattern of author’s search of goat literature. The hallmark of PF is the presence of crusting, scaling, and alopecia. In caprine acantholytic keratinocytes (Fig 2). These patients, it is reported generalized over the Drugs have been implicated in trigger- are the immature cells of the epidermis body and the teats in females.1 ing PF. This happens when the drug whose desmosomes have been broken. induces acantholysis, activates proteolytic They have the appearance of rounded, Pemphigus Erythematosus enzymes that disrupt desmosomes leading darkly stained cells with prominent nuclei. The more benign form of the superfcial to acanthoylsis, or stimulates autoantibod- Other fndings can include nondegener- pemphigus complex, PE, generally limits ies against the desmosomes. Some drugs ated neutrophils and eosinophils.2 These clinical signs to the facial region, including that may be implicated are cephalexin, fndings are highly suggestive of PF, but depigmentation of the nose. Some consider amoxicillin, clavulanic acid, and cimetidine. dermatophytosis and pyoderma can also it to be a crossover between PF and dis- It is often diffcult to prove which drug in present with these cytological fndings. coid lupus erythematosus (DLE). Lupus ery- the patient’s history is at fault.2,3 This must be ruled out with a fungal thematosus will be discussed later in this culture because the immunosuppressive VETERINARY NURSING IN ACTION | JUN/JUL 2017 33 VETERINARY NURSING EDUCATION drugs used to treat PF are not recom- Treatment Options For mended for dermatophytosis.2 Pemphigus Foliaceus Histopathology For mild cases of PF, topical glucocorti- A biopsy should be submitted (ideally) to a coids (GCs) can be used to treat lesions. dermatohistopathologist for fnal diagno- Topical steroids can cause skin atrophy, sis of PF. A 6mm punch biopsy of at least so the patient must be monitored. For three different sites is recommended. If more severe cases, systemic GCs are the an intact pustule and/or crust is included, most common treatment. Because cats it is ideal. Equipment needed is a 6mm don’t metabolize prednisone as well as punch biopsy, a formalin jar, iris scissors dogs, they should be prescribed pred- or a scalpel, and forceps. A permanent nisolone. It is not recommended to use Figure 3 marker is used to circle the lesion of inter- injectable long acting GCs. The veterinarian A 6-year-old Australian Shepherd with DLE. est. Some of the instruments used will be needs to be able to adjust the dose based dependent on the personal preference on the patient’s response. Common side In one case, a Nigerian Dwarf goat kid of the doctor performing the procedure. effects observed include polyuria, polydip- developed PF at the age of two months. Amount of bleeding will depend on the sia, and polyphagia. Other, more serious Four weeks after treatment with GCs, site from which the biopsy is taken, so be side effects that can develop are iatrogenic she was still showing signs of fever, even prepared with gauze sponges. The site is Cushing’s disease, gastric ulcers, and dia- though her skin was improving. Gold closed with a non-absorbable or absorb- betes mellitus.2 salts were added to her therapy. The GCs able suture. If the dog is awake, a local were able to be decreased with time and block of approximately 1ml of 2% lido- GCs alone are often not enough to control eventually discontinued. After six months caine is used for analgesia. clinical signs of PF. Azathioprine can be of receiving gold salts, this treatment was used along with GCs or used alone once also able to be discontinued.6 This procedure is clean but not sterile, so it takes effect. It must be noted that this surgical gloves are not required; however, can take weeks, so the veterinarian may LUPUS ERYTHEMATOSUS exam gloves should be worn. Any hair can choose to keep the patient on GCs during Discoid lupus erythematosus be clipped with a pair of scissors, but care that time. Potential side effects of Azathi- A differential diagnosis for PF is Lupus Ery- should be taken not to disturb the crusts aprine can include bone marrow suppres- thematosus. Discoid Lupus Erythematosus or damage the skin. The site should not be sion, hepatotoxicosis, pancreatitis, and GI (DLE) is a fairly benign condition that may prepped as the crusts contain many of the signs, such as vomiting or diarrhea.2 It is be aggravated by ultraviolet light exposure. cells pathologists use to make a diagnosis. important to perform a CBC and chemistry This may be the second most common After the veterinarian has taken the samples, profle regularly to monitor organ function.
Recommended publications
  • The Use of Biologic Agents in the Treatment of Oral Lesions Due to Pemphigus and Behçet's Disease: a Systematic Review
    Davis GE, Sarandev G, Vaughan AT, Al-Eryani K, Enciso R. The Use of Biologic Agents in the Treatment of Oral Lesions due to Pemphigus and Behçet’s Disease: A Systematic Review. J Anesthesiol & Pain Therapy. 2020;1(1):14-23 Systematic Review Open Access The Use of Biologic Agents in the Treatment of Oral Lesions due to Pemphigus and Behçet’s Disease: A Systematic Review Gerald E. Davis II1,2, George Sarandev1, Alexander T. Vaughan1, Kamal Al-Eryani3, Reyes Enciso4* 1Advanced graduate, Master of Science Program in Orofacial Pain and Oral Medicine, Herman Ostrow School of Dentistry of USC, Los Angeles, California, USA 2Assistant Dean of Academic Affairs, Assistant Professor, Restorative Dentistry, Meharry Medical College, School of Dentistry, Nashville, Tennessee, USA 3Assistant Professor of Clinical Dentistry, Division of Periodontology, Dental Hygiene & Diagnostic Sciences, Herman Ostrow School of Dentistry of USC, Los Angeles, California, USA 4Associate Professor (Instructional), Division of Dental Public Health and Pediatric Dentistry, Herman Ostrow School of Dentistry of USC, Los Angeles, California, USA Article Info Abstract Article Notes Background: Current treatments for pemphigus and Behçet’s disease, such Received: : March 11, 2019 as corticosteroids, have long-term serious adverse effects. Accepted: : April 29, 2020 Objective: The objective of this systematic review was to evaluate the *Correspondence: efficacy of biologic agents (biopharmaceuticals manufactured via a biological *Dr. Reyes Enciso, Associate Professor (Instructional), Division source) on the treatment of intraoral lesions associated with pemphigus and of Dental Public Health and Pediatric Dentistry, Herman Ostrow Behçet’s disease compared to glucocorticoids or placebo. School of Dentistry of USC, Los Angeles, California, USA; Email: [email protected].
    [Show full text]
  • General Pathomorpholog.Pdf
    Ukrаiniаn Medicаl Stomаtologicаl Аcаdemy THE DEPАRTАMENT OF PАTHOLOGICАL АNАTOMY WITH SECTIONSL COURSE MАNUАL for the foreign students GENERАL PАTHOMORPHOLOGY Poltаvа-2020 УДК:616-091(075.8) ББК:52.5я73 COMPILERS: PROFESSOR I. STАRCHENKO ASSOCIATIVE PROFESSOR O. PRYLUTSKYI АSSISTАNT A. ZADVORNOVA ASSISTANT D. NIKOLENKO Рекомендовано Вченою радою Української медичної стоматологічної академії як навчальний посібник для іноземних студентів – здобувачів вищої освіти ступеня магістра, які навчаються за спеціальністю 221 «Стоматологія» у закладах вищої освіти МОЗ України (протокол №8 від 11.03.2020р) Reviewers Romanuk A. - MD, Professor, Head of the Department of Pathological Anatomy, Sumy State University. Sitnikova V. - MD, Professor of Department of Normal and Pathological Clinical Anatomy Odessa National Medical University. Yeroshenko G. - MD, Professor, Department of Histology, Cytology and Embryology Ukrainian Medical Dental Academy. A teaching manual in English, developed at the Department of Pathological Anatomy with a section course UMSA by Professor Starchenko II, Associative Professor Prylutsky OK, Assistant Zadvornova AP, Assistant Nikolenko DE. The manual presents the content and basic questions of the topic, practical skills in sufficient volume for each class to be mastered by students, algorithms for describing macro- and micropreparations, situational tasks. The formulation of tests, their number and variable level of difficulty, sufficient volume for each topic allows to recommend them as preparation for students to take the licensed integrated exam "STEP-1". 2 Contents p. 1 Introduction to pathomorphology. Subject matter and tasks of 5 pathomorphology. Main stages of development of pathomorphology. Methods of pathanatomical diagnostics. Methods of pathomorphological research. 2 Morphological changes of cells as response to stressor and toxic damage 8 (parenchimatouse / intracellular dystrophies).
    [Show full text]
  • ON the VIRUS ETIOLOGY of PEMIPHIGUS and DERMATITIS HERPETIFORMIS DUHRING*, Tt A.MARCHIONINI, M.D
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector ON THE VIRUS ETIOLOGY OF PEMIPHIGUS AND DERMATITIS HERPETIFORMIS DUHRING*, tt A.MARCHIONINI, M.D. AND TH. NASEMANN, M.D. The etiology of pemphigus and dermatitis herpetiformis (Duhring) is, as Lever (33) has pointed ont in his recently published monograph (1953), still unknown, despite many clinical investigations and despite much bacteriologic and virus research using older and newer methods. There can be no doubt that the number of virus diseases has increased since modern scientific, (ultrafiltra- tion, ultracentrifuge, electron-microscope, etc.) and newer biological methods (chorionallantois-vaccination, special serological methods, tissue cultures, etc.) have been used on a larger scale in clinical research. Evidence of virus etiology, however, is not always conclusive. What is generally the basis for the assumption of the virus nature of a disease? First of all, we assume on the basis of epidemiology and clinical observations that the disease is iufectious and that we are dealing with a disease of a special character (morbus sui qeneris). Furthermore, it must be ruled out that bacteria, protozoa and other non-virus agents are responsible for the disease. This can be done by transfer tests with bacteria-free ultrafiltrates. If these are successful, final prcof of the virus etiology has to be established by isolation of the causative agent and its cultivation in a favorable host-organism through numerous transfers. Let us look now from this point of view at pemphigus and dermatitis herpetiformis (Duhring). We are not dealing here with the old controversy, whether both diseases are caused by the same virus (unitarian theory) or by two different viruses (dualistic theory) or are due to two variants of different virulence of the same virus (Duhring-virus-attenu- ated form).
    [Show full text]
  • The Neumann Type of Pemphigus Vegetans Treated with Combination of Dapsone and Steroid
    YM Son, et al Ann Dermatol Vol. 23, Suppl. 3, 2011 http://dx.doi.org/10.5021/ad.2011.23.S3.S310 CASE REPORT The Neumann Type of Pemphigus Vegetans Treated with Combination of Dapsone and Steroid Young-Min Son, M.D., Hong-Kyu Kang, M.D., Jeong-Hwan Yun, M.D., Joo-Young Roh, M.D., Jong-Rok Lee, M.D. Department of Dermatology, Gachon University of Medicine and Science, Gil Hospital, Incheon, Korea Pemphigus vegetans is a rare variant of pemphigus vulgaris INTRODUCTION and is characterized by vegetating lesions in the inguinal folds and mouth and by the presence of autoantibodies Pemphigus diseases are a group of autoimmune disorders against desmoglein 3. Two clinical subtypes of pemphigus that have certain common features, and these diseases are vegetans exist, which are initially characterized by flaccid considered to be potentially fatal1,2. Pemphigus vegetans bullae and erosions (the Neumann subtype) or pustules (the is a variant of pemphigus vulgaris and is the rarest form of Hallopeau subtype). Both subtypes subsequently develop pemphigus; Pemphigus vegetans comprises less than 1∼ into hyperpigmented vegetative plaques with pustules and 2% of all pemphigus cases1,3,4. This variant is charac- hypertrophic granulation tissue at the periphery of the terized by flaccid bullae or pustules that erode to form hy- lesions. Oral administration of corticosteroids alone does not pertrophic papillated plaques that predominantly involve always induce disease remission in patients with pemphigus the intertriginous areas, the scalp, and the face; in 60∼ vegetans. We report here on a 63-year-old woman with 80% of all cases, the oral mucosa are also affected5,6.
    [Show full text]
  • Vesiculobullous Diseases Larkin Community Hospital/NSU-COM Presenters: Yuri Kim, DO, Sam Ecker, DO, Jennifer David, DO, MBA
    Vesiculobullous Diseases Larkin Community Hospital/NSU-COM Presenters: Yuri Kim, DO, Sam Ecker, DO, Jennifer David, DO, MBA Program Director: Stanley Skopit, DO, MSE, FAOCD, FAAD •We have no relevant disclosures Topics of Discussion • Subcorneal Vesiculobullous Disorders – Pemphigus foliaceous – Pemphigus erythematosus – Subcorneal pustular dermatosis (Sneddon-Wilkinson Disease) – Acute Generalized Exanthematous Pustulosis • Intraepidermal Vesiculobullous Disorders – Pemphigus vulgaris – Pemphigus vegetans – Hailey-Hailey Disease – Darier’s Disease – Grover’s Disease – Paraneoplastic Pemphigus – IgA Pemphigus Topics of Discussion (Continued) • Pauci-inflammatory Subepidermal Vesiculobullous Disorders – Porphyria Cutanea Tarda (PCT) – Epidermolysis Bullosa Acquisita (EBA) – Pemphigoid Gestationis • Inflammatory Subepidermal Disorders – Bullous Pemphigoid – Cicatricial Pemphigoid – Dermatitis Herpetiformis – Linear IgA Subcorneal Vesiculobullous Disorders • Pemphigus foliaceous • Pemphigus erythematosus • Subcorneal pustular dermatosis (Sneddon- Wilkinson Disease) • AGEP Pemphigus Foliaceous • IgG Ab to desmoglein 1 (Dsg-1, 160 kDa) • Peak onset middle age, no gender preference • Endemic form – Fogo selvagem in Brazil and other parts of South America • Pemphigus erythematosus- Localized variant of pemphigus foliaceous with features of lupus erythematosus Overview Clinical H&E DIF Treatment Pemphigus Foliaceous Overview Clinical H&E DIF Treatment Pemphigus Foliaceous Overview Clinical H&E DIF Treatment Pemphigus Foliaceous Overview Clinical
    [Show full text]
  • Psoriasis, a Systemic Disease Beyond the Skin, As Evidenced by Psoriatic Arthritis and Many Comorbities
    1 Psoriasis, a Systemic Disease Beyond the Skin, as Evidenced by Psoriatic Arthritis and Many Comorbities – Clinical Remission with a Leishmania Amastigotes Vaccine, a Serendipity Finding J.A. O’Daly Astralis Ltd, Irvington, NJ USA 1. Introduction Psoriasis is a systemic chronic, relapsing inflammatory skin disorder, with worldwide distribution, affects 1–3% of the world population, prevalence varies according to race, geographic location, and environmental factors (Chandran & Raychaudhuri, 2010; Christophers & Mrowietz, 2003; Farber & Nall, 1974). In Germany, 33,981 from 1,344,071 continuously insured persons in 2005 were diagnosed with psoriasis; thus the one year prevalence was 2.53% in the study group. Up to the age of 80 years the prevalence rate (range: 3.99-4.18%) was increasing with increasing age and highest for the age groups from 50 to 79 years The total rate of psoriasis in children younger than 18 years was 0.71%. The prevalence rates increased in an approximately linear manner from 0.12% at the age of 1 year to 1.2% at the age of 18 years (Schäfer et al., 2011). In France, a case-control study in 6,887 persons, 356 cases were identified (5.16%), who declared having had psoriasis during the previous 12 months (Wolkenstein et al., 2009). The prevalence of psoriasis analyzed across Italy showed that 2.9% of Italians declared suffering from psoriasis (regional range: 0.8-4.5%) in a total of 4109 individuals (Saraceno et al., 2008). The overall rate of comorbidity in subjects with psoriasis aged less than 20 years was twice as high as in subjects without psoriasis.
    [Show full text]
  • Medicare Human Services (DHHS) Centers for Medicare & Coverage Issues Manual Medicaid Services (CMS) Transmittal 155 Date: MAY 1, 2002
    Department of Health & Medicare Human Services (DHHS) Centers for Medicare & Coverage Issues Manual Medicaid Services (CMS) Transmittal 155 Date: MAY 1, 2002 CHANGE REQUEST 2149 HEADER SECTION NUMBERS PAGES TO INSERT PAGES TO DELETE Table of Contents 2 1 45-30 - 45-31 2 2 NEW/REVISED MATERIAL--EFFECTIVE DATE: October 1, 2002 IMPLEMENTATION DATE: October 1, 2002 Section 45-31, Intravenous Immune Globulin’s (IVIg) for the Treatment of Autoimmune Mucocutaneous Blistering Diseases, is added to provide limited coverage for the use of IVIg for the treatment of biopsy-proven (1) Pemphigus Vulgaris, (2) Pemphigus Foliaceus, (3) Bullous Pemphigoid, (4) Mucous Membrane Pemphigoid (a.k.a., Cicatricial Pemphigoid), and (5) Epidermolysis Bullosa Acquisita. Use J1563 to bill for IVIg for the treatment of biopsy-proven (1) Pemphigus Vulgaris, (2) Pemphigus Foliaceus, (3) Bullous Pemphigoid, (4) Mucous Membrane Pemphigoid, and (5) Epidermolysis Bullosa Acquisita. This revision to the Coverage Issues Manual is a national coverage decision (NCD). The NCDs are binding on all Medicare carriers, intermediaries, peer review organizations, health maintenance organizations, competitive medical plans, and health care prepayment plans. Under 42 CFR 422.256(b), an NCD that expands coverage is also binding on a Medicare+Choice Organization. In addition, an administrative law judge may not review an NCD. (See §1869(f)(1)(A)(i) of the Social Security Act.) These instructions should be implemented within your current operating budget. DISCLAIMER: The revision date and transmittal number only apply to the redlined material. All other material was previously published in the manual and is only being reprinted. CMS-Pub.
    [Show full text]
  • 'Spongiosis' Dermatitis With
    Spongiosis Spongiosis and Spongiotic • What is ‘spongiosis’? – Intra-epidermal and Dermatitis intercellular edema • Widening of intercellular spaces between keratinocytes • Elongation of G.Peter Sarantopoulos, MD intercellular bridges UCLA Medical Center Spongiosis vs. Spongiotic Spongiosis Dermatitis • ‘Spongiosis’ as a histologic concept (not a • Not everything ‘spongiotic’ is a diagnosis!) spongiotic dermatitis – Intra-epidermal edema accompanies many (if not all) inflammatory skin diseases to some degree • So-called ‘patterns of spongiosis’ • Important to distinguish spongiosis as… – Neutrophilic – The predominant histologic finding – Eosinophilic – A non-specific feature of other inflammatory – Follicular dermatoses (e.g. lichenoid/interface, vasculopathic, – Miliarial psoriasiform, etc) – Sometimes, there is overlap Dermatitis with ‘Spongiosis’ Dermatitis with ‘Spongiosis’ * Neutrophilic: Eosinophilic: Miliarial: Neutrophilic: Eosinophilic: Miliarial: Pustular psoriasis Pemphigus (precursor) M. Crystallina Pustular psoriasis Pemphigus (precursor) M. Crystallina Reiter’s syndrome Pemphigus vegetans M. Rubra Reiter’s syndrome Pemphigus vegetans M. Rubra IgA Pemphigus Bullous pemphigoid M. profunda IgA Pemphigus Bullous pemphigoid M. profunda Pemphigus herpetiformis Cicatricial pemphigoid Pemphigus herpetiformis Cicatricial pemphigoid Infantile acropustulosis Pemphigoid (herpes) Infantile acropustulosis Pemphigoid (herpes) AGEP gestationis Follicular: AGEP gestationis Follicular: Palmoplantar pustulosis Idiopathic eosinophilic Infundibulofolliculitis
    [Show full text]
  • Celiac Disease and Nonceliac Gluten Sensitivitya Review
    Clinical Review & Education JAMA | Review Celiac Disease and Nonceliac Gluten Sensitivity A Review Maureen M. Leonard, MD, MMSc; Anna Sapone, MD, PhD; Carlo Catassi, MD, MPH; Alessio Fasano, MD CME Quiz at IMPORTANCE The prevalence of gluten-related disorders is rising, and increasing numbers of jamanetwork.com/learning individuals are empirically trying a gluten-free diet for a variety of signs and symptoms. This review aims to present current evidence regarding screening, diagnosis, and treatment for celiac disease and nonceliac gluten sensitivity. OBSERVATIONS Celiac disease is a gluten-induced immune-mediated enteropathy characterized by a specific genetic genotype (HLA-DQ2 and HLA-DQ8 genes) and autoantibodies (antitissue transglutaminase and antiendomysial). Although the inflammatory process specifically targets the intestinal mucosa, patients may present with gastrointestinal signs or symptoms, extraintestinal signs or symptoms, or both, Author Affiliations: Center for Celiac suggesting that celiac disease is a systemic disease. Nonceliac gluten sensitivity Research and Treatment, Division of is diagnosed in individuals who do not have celiac disease or wheat allergy but who Pediatric Gastroenterology and Nutrition, MassGeneral Hospital for have intestinal symptoms, extraintestinal symptoms, or both, related to ingestion Children, Boston, Massachusetts of gluten-containing grains, with symptomatic improvement on their withdrawal. The (Leonard, Sapone, Catassi, Fasano); clinical variability and the lack of validated biomarkers for nonceliac gluten sensitivity make Celiac Research Program, Harvard establishing the prevalence, reaching a diagnosis, and further study of this condition Medical School, Boston, Massachusetts (Leonard, Sapone, difficult. Nevertheless, it is possible to differentiate specific gluten-related disorders from Catassi, Fasano); Shire, Lexington, other conditions, based on currently available investigations and algorithms.
    [Show full text]
  • Conditions Related to Inflammatory Arthritis
    Conditions Related to Inflammatory Arthritis There are many conditions related to inflammatory arthritis. Some exhibit symptoms similar to those of inflammatory arthritis, some are autoimmune disorders that result from inflammatory arthritis, and some occur in conjunction with inflammatory arthritis. Related conditions are listed for information purposes only. • Adhesive capsulitis – also known as “frozen shoulder,” the connective tissue surrounding the joint becomes stiff and inflamed causing extreme pain and greatly restricting movement. • Adult onset Still’s disease – a form of arthritis characterized by high spiking fevers and a salmon- colored rash. Still’s disease is more common in children. • Caplan’s syndrome – an inflammation and scarring of the lungs in people with rheumatoid arthritis who have exposure to coal dust, as in a mine. • Celiac disease – an autoimmune disorder of the small intestine that causes malabsorption of nutrients and can eventually cause osteopenia or osteoporosis. • Dermatomyositis – a connective tissue disease characterized by inflammation of the muscles and the skin. The condition is believed to be caused either by viral infection or an autoimmune reaction. • Diabetic finger sclerosis – a complication of diabetes, causing a hardening of the skin and connective tissue in the fingers, thus causing stiffness. • Duchenne muscular dystrophy – one of the most prevalent types of muscular dystrophy, characterized by rapid muscle degeneration. • Dupuytren’s contracture – an abnormal thickening of tissues in the palm and fingers that can cause the fingers to curl. • Eosinophilic fasciitis (Shulman’s syndrome) – a condition in which the muscle tissue underneath the skin becomes swollen and thick. People with eosinophilic fasciitis have a buildup of eosinophils—a type of white blood cell—in the affected tissue.
    [Show full text]
  • Pemphigus. S2 Guideline for Diagnosis and Treatment
    DOI: 10.1111/jdv.12772 JEADV GUIDELINES Pemphigus. S2 Guideline for diagnosis and treatment – guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV) M. Hertl,1,* H. Jedlickova,2 S. Karpati,3 B. Marinovic,4 S. Uzun,5 S. Yayli,6 D. Mimouni,7 L. Borradori,8 C. Feliciani,9 D. Ioannides,10 P. Joly,11 C. Kowalewski,12 G. Zambruno,13 D. Zillikens,14 M.F. Jonkman15 1Department of Dermatology, Philipps-University Marburg, Marburg, Germany 2Department of Dermatology, Masaryk University, Brno, Czech Republic 3Department of Dermatology, Semmelweis University Budapest, Budapest, Hungary 4Department of Dermatology, School of Medicine University of Zagreb, Zagreb, Croatia 5Department of Dermatology, Akdeniz University, Antalya, Turkey 6Department of Dermatology, Karadeniz Technical University, Trabzon, Turkey 7Department of Dermatology, Tel-Aviv University, Tel-Aviv, Israel 8Department of Dermatology, University of Bern, Inselspital, Switzerland 9Department of Dermatology, University of Parma, Parma, Italy 10Department of Dermatology, Aristotle University of Thessaloniki, Thessaloniki, Greece 11Department of Dermatology, Rouen University Hospital, Rouen, France 12Department of Dermatology, Medical University of Warsaw, Warsaw, Poland 13Department of Dermatology, L’Istituto Dermopatico dell’Immacolata, Rome, Italy 14Department of Dermatology, University of Lubeck,€ Lubeck,€ Germany 15Department of Dermatology, University of Groningen, Groningen, The Netherlands *Correspondence: M. Hertl. E-mail: [email protected] Abstract Background Pemphigus encompasses a group of life-threatening autoimmune bullous diseases characterized by blis- ters and erosions of the mucous membranes and skin. Before the era of immunosuppressive treatment, the prognosis of pemphigus was almost fatal. Due to its rarity, only few prospective controlled therapeutic trials are available.
    [Show full text]
  • Pemphigus Foliaceus Igg Causes Dissociation of Desmoglein 1– Containing Junctions Without Blocking Desmoglein 1 Transinteraction
    Pemphigus foliaceus IgG causes dissociation of desmoglein 1– containing junctions without blocking desmoglein 1 transinteraction Jens Waschke, … , Detlef Zillikens, Detlev Drenckhahn J Clin Invest. 2005;115(11):3157-3165. https://doi.org/10.1172/JCI23475. Research Article Dermatology Autoantibodies against the epidermal desmosomal cadherins desmoglein 1 (Dsg1) and Dsg3 have been shown to cause severe to lethal skin blistering clinically defined as pemphigus foliaceus (PF) and pemphigus vulgaris (PV). It is unknown whether antibody-induced dissociation of keratinocytes is caused by direct inhibition of Dsg1 transinteraction or by secondary cellular responses. Here we show in an in vitro system that IgGs purified from PF patient sera caused cellular dissociation of cultured human keratinocytes as well as significant release of Dsg1-coated microbeads attached to Dsg- containing sites on the keratinocyte cellular surface. However, cell dissociation and bead release induced by PF-IgGs was not caused by direct steric hindrance of Dsg1 transinteraction, as demonstrated by single molecule atomic force measurements and by laser trapping of surface-bound Dsg1-coated microbeads. Rather, our experiments strongly indicate that PF-IgG–mediated dissociation events must involve autoantibody-triggered cellular signaling pathways, resulting in destabilization of Dsg1-based adhesive sites and desmosomes. Find the latest version: https://jci.me/23475/pdf Research article Pemphigus foliaceus IgG causes dissociation of desmoglein 1–containing junctions without blocking desmoglein 1 transinteraction Jens Waschke,1 Paola Bruggeman,1 Werner Baumgartner,1 Detlef Zillikens,2 and Detlev Drenckhahn1 1Institute of Anatomy and Cell Biology, University of Würzburg, Würzburg, Germany. 2Department of Dermatology, University of Lübeck, Lübeck, Germany. Autoantibodies against the epidermal desmosomal cadherins desmoglein 1 (Dsg1) and Dsg3 have been shown to cause severe to lethal skin blistering clinically defined as pemphigus foliaceus (PF) and pemphigus vulgaris (PV).
    [Show full text]